Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference

INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ — Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer and Hyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44^th Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 12–15, 2026.

Celltrion’s presentation and fireside chat are scheduled for Tuesday, January 13, 2026, from 3:45 PM to 4:25 PM (PT) at the Grand Ballroom, The Westin St. Francis San Francisco Union Square.

About Celltrion, Inc.

Celltrion, Inc. is a leading biopharmaceutical company that specializes in researching, developing, manufacturing, marketing and sales of innovative therapeutics that improve people’s lives worldwide. Celltrion, Inc. is a pioneer in the biosimilar space, having launched the world’s first monoclonal antibody biosimilar. Our global pharmaceutical portfolio addresses a range of therapeutic areas including immunology, oncology, hematology, ophthalmology and endocrinology. Built on trust through our fully integrated capabilities – from advanced R&D and in-house manufacturing to a reliable global supply network – we continue moving toward innovation as we work to ensure consistent availability of affordable, trusted, and high-quality biosimilars and biologics for patients and healthcare systems across the globe.

For more information, please visit our website www.celltrion.com/en-us and stay updated with our latest news and events on our social media – LinkedIn, Instagram, X, and Facebook.

US–25-00145

For further information please contact:

Global PR Team
globalpr@celltrion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/celltrion-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302654432.html

SOURCE Celltrion